AMPHOTERICIN B Drug Patent Profile
✉ Email this page to a colleague
When do Amphotericin B patents expire, and when can generic versions of Amphotericin B launch?
Amphotericin B is a drug marketed by Eugia Pharma, Spil, Abbott, Abraxis Pharm, Teva Parenteral, and Xgen Pharms. and is included in six NDAs.
The generic ingredient in AMPHOTERICIN B is amphotericin b. There are fifteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the amphotericin b profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Amphotericin B
A generic version of AMPHOTERICIN B was approved as amphotericin b by XGEN PHARMS on April 29th, 1992.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AMPHOTERICIN B?
- What are the global sales for AMPHOTERICIN B?
- What is Average Wholesale Price for AMPHOTERICIN B?
Summary for AMPHOTERICIN B
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 62 |
| Clinical Trials: | 170 |
| Drug Prices: | Drug price information for AMPHOTERICIN B |
| DailyMed Link: | AMPHOTERICIN B at DailyMed |
Recent Clinical Trials for AMPHOTERICIN B
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Federal University of Health Science of Porto Alegre | Phase 3 |
| Huashan Hospital | Phase 4 |
| Helwan University | N/A |
Pharmacology for AMPHOTERICIN B
Medical Subject Heading (MeSH) Categories for AMPHOTERICIN B
Anatomical Therapeutic Chemical (ATC) Classes for AMPHOTERICIN B
US Patents and Regulatory Information for AMPHOTERICIN B
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eugia Pharma | AMPHOTERICIN B | amphotericin b | INJECTABLE, LIPOSOMAL;INJECTION | 214010-001 | Nov 17, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Abraxis Pharm | AMPHOTERICIN B | amphotericin b | INJECTABLE;INJECTION | 062728-001 | Apr 13, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Spil | AMPHOTERICIN B | amphotericin b | INJECTABLE, LIPOSOMAL;INJECTION | 212514-001 | Dec 14, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Abbott | AMPHOTERICIN B | amphotericin b | INJECTABLE;INJECTION | 064141-001 | Dec 23, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Xgen Pharms | AMPHOTERICIN B | amphotericin b | INJECTABLE;INJECTION | 063206-001 | Apr 29, 1992 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
